| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 1.36e-06 | 5 | 104 | 3 | GO:0031821 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 8.07e-06 | 25 | 104 | 4 | GO:0031683 | |
| GeneOntologyMolecularFunction | N-acylphosphatidylethanolamine-specific phospholipase D activity | 8.03e-05 | 3 | 104 | 2 | GO:0070290 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 1.25e-04 | 19 | 104 | 3 | GO:0032794 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAD51D ABCA3 ATP7B ABCC9 ATP9B MMAA CCT6A KIF15 ABCB11 GNAI1 GNAI2 GNAI3 GNAO1 | 1.93e-04 | 775 | 104 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAD51D ABCA3 ATP7B ABCC9 ATP9B MMAA CCT6A KIF15 ABCB11 GNAI1 GNAI2 GNAI3 GNAO1 | 4.15e-04 | 839 | 104 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAD51D ABCA3 ATP7B ABCC9 ATP9B MMAA CCT6A KIF15 ABCB11 GNAI1 GNAI2 GNAI3 GNAO1 | 4.20e-04 | 840 | 104 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAD51D ABCA3 ATP7B ABCC9 ATP9B MMAA CCT6A KIF15 ABCB11 GNAI1 GNAI2 GNAI3 GNAO1 | 4.20e-04 | 840 | 104 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.97e-04 | 441 | 104 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | phospholipase D activity | 7.37e-04 | 8 | 104 | 2 | GO:0004630 | |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC170 RAD51D CENPU PTPN23 ECPAS CLIP1 SMTN TTLL12 ACTR1B ALMS1 KIF15 ROCK1 GNAI1 GNAI2 GNAI3 CDK6 | 1.96e-05 | 919 | 108 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 3.12e-05 | 35 | 108 | 4 | GO:0005834 | |
| GeneOntologyCellularComponent | GTPase complex | 5.89e-05 | 41 | 108 | 4 | GO:1905360 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 2.01e-04 | 56 | 108 | 4 | GO:0031234 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 4.88e-04 | 443 | 108 | 9 | GO:0098791 | |
| GeneOntologyCellularComponent | centrosome | RAD51D CENPU ECPAS CLIP1 TTLL12 ACTR1B ALMS1 KIF15 GNAI1 GNAI2 GNAI3 CDK6 | 6.28e-04 | 770 | 108 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | endosome | ABCA3 GGA2 ANKFY1 ATP7B VPS13C PTPN23 ATP9B ECPAS CLIP1 LDLR TAB3 SORT1 MELTF ABCB11 PLD1 | 9.67e-04 | 1167 | 108 | 15 | GO:0005768 |
| GeneOntologyCellularComponent | lamellipodium | 1.25e-03 | 230 | 108 | 6 | GO:0030027 | |
| GeneOntologyCellularComponent | pinosome | 1.41e-03 | 11 | 108 | 2 | GO:0044352 | |
| GeneOntologyCellularComponent | macropinosome | 1.41e-03 | 11 | 108 | 2 | GO:0044354 | |
| Domain | Gprotein_alpha_I | 6.49e-08 | 8 | 105 | 4 | IPR001408 | |
| Domain | LRRC37AB_C | 6.88e-07 | 4 | 105 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 6.88e-07 | 4 | 105 | 3 | PF14914 | |
| Domain | LRRC37_N | 6.88e-07 | 4 | 105 | 3 | IPR032754 | |
| Domain | LRRC37 | 6.88e-07 | 4 | 105 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 6.88e-07 | 4 | 105 | 3 | IPR015753 | |
| Domain | GproteinA_insert | 1.63e-06 | 16 | 105 | 4 | IPR011025 | |
| Domain | - | 1.63e-06 | 16 | 105 | 4 | 1.10.400.10 | |
| Domain | G-alpha | 1.63e-06 | 16 | 105 | 4 | PF00503 | |
| Domain | G_alpha | 1.63e-06 | 16 | 105 | 4 | SM00275 | |
| Domain | Gprotein_alpha_su | 2.12e-06 | 17 | 105 | 4 | IPR001019 | |
| Domain | PLipase_D1/D2 | 3.13e-05 | 2 | 105 | 2 | IPR016555 | |
| Domain | PLipase_D_fam | 3.13e-05 | 2 | 105 | 2 | IPR015679 | |
| Domain | LAM_G_DOMAIN | 6.01e-05 | 38 | 105 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 7.38e-05 | 40 | 105 | 4 | PF02210 | |
| Domain | PLDc_2 | 9.36e-05 | 3 | 105 | 2 | PF13091 | |
| Domain | PLD-like_dom | 9.36e-05 | 3 | 105 | 2 | IPR025202 | |
| Domain | LamG | 1.08e-04 | 44 | 105 | 4 | SM00282 | |
| Domain | PLDc | 1.86e-04 | 4 | 105 | 2 | PF00614 | |
| Domain | Laminin_G | 3.17e-04 | 58 | 105 | 4 | IPR001791 | |
| Domain | PLDc | 4.63e-04 | 6 | 105 | 2 | SM00155 | |
| Domain | PLipase_D/transphosphatidylase | 6.45e-04 | 7 | 105 | 2 | IPR001736 | |
| Domain | PLD | 6.45e-04 | 7 | 105 | 2 | PS50035 | |
| Domain | Pkinase_C | 1.17e-03 | 37 | 105 | 3 | IPR017892 | |
| Domain | AAA | 1.32e-03 | 144 | 105 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.32e-03 | 144 | 105 | 5 | IPR003593 | |
| Domain | ConA-like_dom | 1.49e-03 | 219 | 105 | 6 | IPR013320 | |
| Domain | GAIN_dom_N | 1.67e-03 | 11 | 105 | 2 | IPR032471 | |
| Domain | GAIN | 1.67e-03 | 11 | 105 | 2 | PF16489 | |
| Domain | Pkinase_C | 1.69e-03 | 42 | 105 | 3 | PF00433 | |
| Domain | ABC_transporter_CS | 1.69e-03 | 42 | 105 | 3 | IPR017871 | |
| Domain | Galactose-bd-like | 1.95e-03 | 94 | 105 | 4 | IPR008979 | |
| Domain | EGF | 2.13e-03 | 235 | 105 | 6 | SM00181 | |
| Domain | EGF_3 | 2.13e-03 | 235 | 105 | 6 | PS50026 | |
| Domain | ABC_tran | 2.49e-03 | 48 | 105 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.49e-03 | 48 | 105 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.64e-03 | 49 | 105 | 3 | PS00211 | |
| Domain | PH_dom-like | 2.79e-03 | 426 | 105 | 8 | IPR011993 | |
| Domain | ABC_transporter-like | 2.79e-03 | 50 | 105 | 3 | IPR003439 | |
| Domain | EGF-like_dom | 2.84e-03 | 249 | 105 | 6 | IPR000742 | |
| Domain | EGF_1 | 3.19e-03 | 255 | 105 | 6 | PS00022 | |
| Domain | EGF_2 | 3.85e-03 | 265 | 105 | 6 | PS01186 | |
| Domain | AGC-kinase_C | 3.86e-03 | 56 | 105 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.86e-03 | 56 | 105 | 3 | PS51285 | |
| Domain | S_TK_X | 3.86e-03 | 56 | 105 | 3 | SM00133 | |
| Domain | PH | 4.85e-03 | 278 | 105 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.94e-03 | 279 | 105 | 6 | PS50003 | |
| Domain | PH_domain | 5.02e-03 | 280 | 105 | 6 | IPR001849 | |
| Domain | ZF_DAG_PE_1 | 5.61e-03 | 64 | 105 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.61e-03 | 64 | 105 | 3 | PS50081 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 9.69e-07 | 14 | 81 | 4 | M64 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 2.06e-06 | 66 | 81 | 6 | M39684 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 4.48e-06 | 43 | 81 | 5 | M238 | |
| Pathway | PID_S1P_S1P1_PATHWAY | 5.62e-06 | 21 | 81 | 4 | M103 | |
| Pathway | PID_S1P_META_PATHWAY | 5.62e-06 | 21 | 81 | 4 | M155 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 9.85e-06 | 24 | 81 | 4 | M268 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.00e-05 | 8 | 81 | 3 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.00e-05 | 8 | 81 | 3 | M47643 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.37e-05 | 26 | 81 | 4 | M47553 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.50e-05 | 9 | 81 | 3 | M47641 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 2.15e-05 | 29 | 81 | 4 | M55 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 2.83e-05 | 31 | 81 | 4 | M213 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 2.92e-05 | 11 | 81 | 3 | M47797 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 3.49e-05 | 65 | 81 | 5 | M15 | |
| Pathway | WP_PURINERGIC_SIGNALING | 3.65e-05 | 33 | 81 | 4 | M39855 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 3.87e-05 | 12 | 81 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 3.87e-05 | 12 | 81 | 3 | M47559 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 5.78e-05 | 37 | 81 | 4 | M42558 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 6.36e-05 | 14 | 81 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 6.36e-05 | 14 | 81 | 3 | M750 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 7.90e-05 | 40 | 81 | 4 | M41 | |
| Pathway | PID_CXCR3_PATHWAY | 1.05e-04 | 43 | 81 | 4 | M222 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.17e-04 | 17 | 81 | 3 | M47544 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 1.62e-04 | 48 | 81 | 4 | M219 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 2.60e-04 | 22 | 81 | 3 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 2.60e-04 | 22 | 81 | 3 | M841 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 2.98e-04 | 23 | 81 | 3 | MM15952 | |
| Pathway | REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY | 3.22e-04 | 5 | 81 | 2 | M45016 | |
| Pathway | REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY | 3.22e-04 | 5 | 81 | 2 | MM15696 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 3.41e-04 | 105 | 81 | 5 | M164 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 3.84e-04 | 25 | 81 | 3 | M39384 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 4.66e-04 | 63 | 81 | 4 | M8 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S | 4.82e-04 | 6 | 81 | 2 | M47461 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.84e-04 | 27 | 81 | 3 | M47519 | |
| Pathway | BIOCARTA_CB1R_PATHWAY | 6.72e-04 | 7 | 81 | 2 | MM1569 | |
| Pathway | BIOCARTA_CB1R_PATHWAY | 6.72e-04 | 7 | 81 | 2 | M22054 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 6.95e-04 | 70 | 81 | 4 | M8232 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 8.81e-04 | 33 | 81 | 3 | MM15020 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 8.81e-04 | 33 | 81 | 3 | M9379 | |
| Pathway | REACTOME_SYNTHESIS_OF_PG | 8.93e-04 | 8 | 81 | 2 | M26961 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.08e-03 | 450 | 81 | 9 | M27078 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483 | 1.14e-03 | 9 | 81 | 2 | M49010 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S | 1.42e-03 | 10 | 81 | 2 | M47418 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.44e-03 | 39 | 81 | 3 | MM14496 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S | 1.73e-03 | 11 | 81 | 2 | M47426 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.78e-03 | 90 | 81 | 4 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.85e-03 | 91 | 81 | 4 | M39426 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.91e-03 | 43 | 81 | 3 | M29837 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.91e-03 | 43 | 81 | 3 | M954 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.04e-03 | 44 | 81 | 3 | M11911 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.04e-03 | 44 | 81 | 3 | MM15709 | |
| Pathway | WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION | 2.07e-03 | 12 | 81 | 2 | M39802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S | 2.07e-03 | 12 | 81 | 2 | M47417 | |
| Pathway | REACTOME_GPER1_SIGNALING | 2.18e-03 | 45 | 81 | 3 | M45008 | |
| Pathway | PID_RHOA_PATHWAY | 2.18e-03 | 45 | 81 | 3 | M12 | |
| Pathway | WP_EGFEGFR_SIGNALING | 2.39e-03 | 162 | 81 | 5 | M39334 | |
| Pathway | BIOCARTA_EFP_PATHWAY | 2.44e-03 | 13 | 81 | 2 | MM1537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066 | 2.44e-03 | 13 | 81 | 2 | M47416 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S | 2.44e-03 | 13 | 81 | 2 | M49035 | |
| Pathway | PID_CXCR4_PATHWAY | 2.61e-03 | 100 | 81 | 4 | M124 | |
| Pathway | WP_RETT_SYNDROME | 2.62e-03 | 48 | 81 | 3 | M39759 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 2.62e-03 | 48 | 81 | 3 | M10775 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ANKFY1 DSP ACBD5 CENPU CHN2 CLIP1 CDC42BPB CCT6A ROCK1 PLD1 PLD2 | 2.65e-03 | 720 | 81 | 11 | M41838 |
| Pathway | KEGG_MELANOGENESIS | 2.71e-03 | 101 | 81 | 4 | M7761 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.78e-03 | 49 | 81 | 3 | M41832 | |
| Pathway | PID_ARF6_TRAFFICKING_PATHWAY | 2.78e-03 | 49 | 81 | 3 | M67 | |
| Pathway | PID_ARF6_DOWNSTREAM_PATHWAY | 3.26e-03 | 15 | 81 | 2 | M120 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S | 3.26e-03 | 15 | 81 | 2 | M47524 | |
| Pubmed | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. | 8.79e-11 | 4 | 108 | 4 | 11248120 | |
| Pubmed | 8.79e-11 | 4 | 108 | 4 | 11771389 | ||
| Pubmed | The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. | 8.79e-11 | 4 | 108 | 4 | 18832081 | |
| Pubmed | 4.39e-10 | 5 | 108 | 4 | 12860983 | ||
| Pubmed | Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. | 4.39e-10 | 5 | 108 | 4 | 2820999 | |
| Pubmed | Characterization of RGS5 in regulation of G protein-coupled receptor signaling. | 1.31e-09 | 6 | 108 | 4 | 11253162 | |
| Pubmed | 3.06e-09 | 7 | 108 | 4 | 15251452 | ||
| Pubmed | 3.06e-09 | 7 | 108 | 4 | 8986788 | ||
| Pubmed | Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. | 6.10e-09 | 8 | 108 | 4 | 12509430 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GGA2 DSP VPS13C TUT7 RNF135 PTPN23 ECPAS CLIP1 EMSY TAB3 ACTR1B NCOR1 CCT6A ALMS1 NADK GNAI3 | 9.28e-09 | 853 | 108 | 16 | 28718761 |
| Pubmed | Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis. | 1.09e-08 | 9 | 108 | 4 | 38651641 | |
| Pubmed | The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. | 1.82e-08 | 10 | 108 | 4 | 8521505 | |
| Pubmed | 1.82e-08 | 10 | 108 | 4 | 26755700 | ||
| Pubmed | 1.82e-08 | 10 | 108 | 4 | 8552586 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 16962188 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 29342363 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 17418106 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 30836096 | ||
| Pubmed | G(o) controls the hyperpolarization-activated current in embryonic stem cell-derived cardiocytes. | 2.91e-08 | 3 | 108 | 3 | 18156202 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 23467353 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15788486 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 17484771 | ||
| Pubmed | Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse. | 4.27e-08 | 12 | 108 | 4 | 2508088 | |
| Pubmed | RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao. | 4.27e-08 | 12 | 108 | 4 | 10926822 | |
| Pubmed | Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. | 6.15e-08 | 13 | 108 | 4 | 8208289 | |
| Pubmed | Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. | 6.15e-08 | 13 | 108 | 4 | 16892066 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 17635935 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 22419166 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 10364213 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 11168387 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 21931697 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 28145731 | ||
| Pubmed | 1.17e-07 | 15 | 108 | 4 | 24478091 | ||
| Pubmed | 1.17e-07 | 15 | 108 | 4 | 11118617 | ||
| Pubmed | 1.55e-07 | 16 | 108 | 4 | 19198609 | ||
| Pubmed | 2.60e-07 | 18 | 108 | 4 | 36445537 | ||
| Pubmed | 2.60e-07 | 18 | 108 | 4 | 20971364 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 9660808 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 26373672 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 16298104 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 22230296 | ||
| Pubmed | Coupling of dopamine receptor subtypes to multiple and diverse G proteins. | 2.90e-07 | 5 | 108 | 3 | 10978845 | |
| Pubmed | Defective macrophage migration in Gαi2- but not Gαi3-deficient mice. | 2.90e-07 | 5 | 108 | 3 | 22706085 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 11387333 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 24415754 | ||
| Pubmed | VGF ANKFY1 MYCBP2 NHSL2 MCC CLIP1 CDC42BPB EMSY NCOR1 CELSR2 KIF15 ROCK1 GNAI1 GNAO1 GOLGB1 | 3.08e-07 | 963 | 108 | 15 | 28671696 | |
| Pubmed | Additive effect of multiple genetic variants on the risk of coronary artery disease. | 3.29e-07 | 19 | 108 | 4 | 20738937 | |
| Pubmed | ANKFY1 MYCBP2 DSP CLIP1 CDC42BPB NCOR1 CCT6A ALMS1 ZNF160 MYBPC1 PLCE1 | 4.51e-07 | 497 | 108 | 11 | 23414517 | |
| Pubmed | Identification of the platelet ADP receptor targeted by antithrombotic drugs. | 5.78e-07 | 6 | 108 | 3 | 11196645 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 16371464 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 9079700 | ||
| Pubmed | Cloning and characterization of a novel regulator of G protein signalling in human platelets. | 5.78e-07 | 6 | 108 | 3 | 11955952 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 25078664 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 29570951 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 23236180 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 19401591 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 30975754 | ||
| Pubmed | The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi resident protein. | 5.78e-07 | 6 | 108 | 3 | 9647645 | |
| Pubmed | MYCBP2 DSP ACBD5 PTPN23 CACHD1 CDC42BPB TAB3 SORT1 NCOR1 UBXN4 KIF15 CEBPZ MKI67 ROCK1 RELL1 | 9.01e-07 | 1049 | 108 | 15 | 27880917 | |
| Pubmed | GGA2 VPS13C ACBD5 CDC42BPB NCOR1 CCT6A UBXN4 MKI67 RELL1 PLD1 SMCR8 PCDH9 GOLGB1 | 9.17e-07 | 777 | 108 | 13 | 35844135 | |
| Pubmed | Activation state-dependent interaction between Galphai and p67phox. | 1.01e-06 | 7 | 108 | 3 | 16782902 | |
| Pubmed | Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. | 1.25e-06 | 26 | 108 | 4 | 19060910 | |
| Pubmed | 1.70e-06 | 28 | 108 | 4 | 8858601 | ||
| Pubmed | ATP7B MYCBP2 VPS13C TUT7 MCC GTF3C4 UBXN4 ALMS1 CEBPZ SECISBP2 ROCK1 HECTD1 | 3.09e-06 | 733 | 108 | 12 | 34672954 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 23064749 | ||
| Pubmed | miR-195b is required for proper cellular homeostasis in the elderly. | 3.80e-06 | 34 | 108 | 4 | 38191655 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCBP2 DSP BACH1 ECPAS PNISR CLIP1 GTF3C4 EMSY SMTN NCOR1 RPAP1 MKI67 | 5.37e-06 | 774 | 108 | 12 | 15302935 |
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 6.28e-06 | 12 | 108 | 3 | 9611134 | |
| Pubmed | 6.58e-06 | 418 | 108 | 9 | 34709266 | ||
| Pubmed | 6.65e-06 | 39 | 108 | 4 | 21909109 | ||
| Pubmed | 7.81e-06 | 322 | 108 | 8 | 26514267 | ||
| Pubmed | A molecular blueprint at the apical surface establishes planar asymmetry in cochlear hair cells. | 8.14e-06 | 13 | 108 | 3 | 24135232 | |
| Pubmed | 8.59e-06 | 549 | 108 | 10 | 38280479 | ||
| Pubmed | ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney. | 9.55e-06 | 2 | 108 | 2 | 16612327 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9813240 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27564114 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32814056 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30369483 | ||
| Pubmed | Platelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice. | 9.55e-06 | 2 | 108 | 2 | 25944935 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27542767 | ||
| Pubmed | To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity. | 9.55e-06 | 2 | 108 | 2 | 30224338 | |
| Pubmed | Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes. | 9.55e-06 | 2 | 108 | 2 | 18694819 | |
| Pubmed | Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1. | 9.55e-06 | 2 | 108 | 2 | 32294430 | |
| Pubmed | Gαi2 and Gαi3 Differentially Regulate Arrest from Flow and Chemotaxis in Mouse Neutrophils. | 9.55e-06 | 2 | 108 | 2 | 26976957 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26988987 | ||
| Pubmed | Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models. | 9.55e-06 | 2 | 108 | 2 | 32661773 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24618697 | ||
| Pubmed | Phospholipase D is essential for keratocyte-like migration of NBT-II cells. | 9.55e-06 | 2 | 108 | 2 | 18344600 | |
| Pubmed | Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. | 9.55e-06 | 2 | 108 | 2 | 26950419 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 34932500 | ||
| Pubmed | Beyond the Cell Cycle: Enhancing the Immune Surveillance of Tumors Via CDK4/6 Inhibition. | 9.55e-06 | 2 | 108 | 2 | 29934327 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12615079 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10790539 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 36362078 | ||
| Pubmed | Gαi2- and Gαi3-deficient mice display opposite severity of myocardial ischemia reperfusion injury. | 9.55e-06 | 2 | 108 | 2 | 24858945 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20188462 | ||
| Pubmed | Organization and alternative splicing of the murine phospholipase D2 gene. | 9.55e-06 | 2 | 108 | 2 | 9560313 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26807827 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37611074 | ||
| Pubmed | Phospholipase D1 Ablation Disrupts Mouse Longitudinal Hippocampal Axis Organization and Functioning. | 9.55e-06 | 2 | 108 | 2 | 32209478 | |
| Interaction | RGS5 interactions | 3.46e-07 | 12 | 106 | 4 | int:RGS5 | |
| Interaction | RIC8A interactions | 7.40e-07 | 96 | 106 | 7 | int:RIC8A | |
| Interaction | RGS16 interactions | 1.63e-06 | 17 | 106 | 4 | int:RGS16 | |
| Interaction | PCP2 interactions | 4.04e-06 | 21 | 106 | 4 | int:PCP2 | |
| Interaction | RGS18 interactions | 1.16e-05 | 9 | 106 | 3 | int:RGS18 | |
| Interaction | GPSM2 interactions | 2.04e-05 | 31 | 106 | 4 | int:GPSM2 | |
| Interaction | GNB5 interactions | 2.93e-05 | 68 | 106 | 5 | int:GNB5 | |
| Interaction | PIK3R4 interactions | 3.76e-05 | 118 | 106 | 6 | int:PIK3R4 | |
| Interaction | RGS19 interactions | 4.18e-05 | 37 | 106 | 4 | int:RGS19 | |
| Interaction | ADRA2A interactions | 6.15e-05 | 15 | 106 | 3 | int:ADRA2A | |
| Interaction | GNG10 interactions | 7.62e-05 | 43 | 106 | 4 | int:GNG10 | |
| Interaction | RGS12 interactions | 9.13e-05 | 45 | 106 | 4 | int:RGS12 | |
| Interaction | CNR1 interactions | 1.09e-04 | 18 | 106 | 3 | int:CNR1 | |
| Cytoband | 3p21.31 | 9.54e-05 | 100 | 108 | 4 | 3p21.31 | |
| Cytoband | 14q32.3 | 2.44e-04 | 10 | 108 | 2 | 14q32.3 | |
| Cytoband | 12q23.2 | 8.19e-04 | 18 | 108 | 2 | 12q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 9.36e-04 | 316 | 108 | 5 | chr3p21 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 4.30e-05 | 3 | 69 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 4.30e-05 | 3 | 69 | 2 | 1189 | |
| GeneFamily | Phospholipases | 5.49e-04 | 42 | 69 | 3 | 467 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.72e-03 | 134 | 69 | 4 | 861 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | VGF ABCA3 MYCBP2 TSHZ2 PCLO GNPTAB CHN2 CLIP1 OTP CMIP CELSR3 KLHL13 TENM1 OPN5 GNAO1 PCDH9 | 1.20e-05 | 1106 | 108 | 16 | M39071 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYCBP2 VPS13C TUT7 GNPTAB CENPU PNISR CLIP1 KIF15 CEBPZ MKI67 HECTD1 GOLGB1 | 1.71e-05 | 656 | 108 | 12 | M18979 |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.97e-05 | 200 | 108 | 7 | M9358 | |
| Coexpression | RB_P130_DN.V1_DN | 2.17e-05 | 136 | 108 | 6 | M2803 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | VPS13C RNF135 LRRC37A2 CACHD1 PNISR CLIP1 NCOR1 L3MBTL1 ALMS1 RELL1 ZNF160 HECTD1 GOLGB1 | 2.83e-05 | 807 | 108 | 13 | M16651 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | 5.27e-05 | 513 | 108 | 10 | M39069 | |
| Coexpression | BENPORATH_NANOG_TARGETS | GNPTAB CNTNAP3 MCC CACHD1 ECPAS PNISR GTF3C4 ACTR1B NCOR1 KIF15 CEBPZ SECISBP2 GNAI1 CDK6 | 5.53e-05 | 988 | 108 | 14 | M6616 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | RAD51D PCLO KBTBD8 PNISR CLIP1 LDLR SORT1 NCOR1 NAA25 ALMS1 CELSR2 KIF15 CEBPZ MKI67 ROCK1 GNAI1 GNAO1 HECTD1 CDK6 | 4.65e-07 | 989 | 107 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | PNISR CLIP1 NCOR1 ALMS1 KIF15 CEBPZ MKI67 ROCK1 GNAI1 HECTD1 | 3.94e-06 | 311 | 107 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ZNF266 PCLO TUT7 GNPTAB PNISR CLIP1 LDLR NCOR1 NAA25 ALMS1 KIF15 CEBPZ MKI67 GNAI1 GNAO1 HECTD1 | 4.07e-06 | 831 | 107 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.79e-05 | 323 | 107 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TSHZ2 ASPN CENPU MCC ABCC9 IL1RL2 MEF2C SMTN KLHL13 MKI67 GNAI1 PCDH9 PLCE1 | 1.45e-04 | 777 | 107 | 13 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | GGA2 ANKFY1 TSHZ2 NHSL2 ASPN BACH1 ABCC9 PNISR MEF2C TRPM5 GNAI2 PCDH9 MYBPC1 | 1.71e-04 | 790 | 107 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | GGA2 ANKFY1 TSHZ2 NHSL2 ASPN BACH1 ABCC9 PNISR MEF2C TRPM5 ROCK1 GNAI2 PCDH9 | 1.91e-04 | 799 | 107 | 13 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 1.96e-04 | 166 | 107 | 6 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 2.07e-04 | 404 | 107 | 9 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PCLO CHN2 PNISR CLIP1 CELSR2 MKI67 SECISBP2 GNAI1 GNAI3 HECTD1 GOLGB1 | 2.08e-04 | 595 | 107 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.58e-04 | 328 | 107 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.45e-09 | 199 | 108 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-07 | 181 | 108 | 7 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-07 | 184 | 108 | 7 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.48e-07 | 185 | 108 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-07 | 187 | 108 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 188 | 108 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-07 | 188 | 108 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.17e-07 | 190 | 108 | 7 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-07 | 193 | 108 | 7 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-06 | 165 | 108 | 6 | 3d14f37b8a9c0ddc1130e60a2e08556bad1fb855 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.46e-06 | 168 | 108 | 6 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-06 | 169 | 108 | 6 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-06 | 173 | 108 | 6 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.24e-06 | 174 | 108 | 6 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.38e-06 | 175 | 108 | 6 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.52e-06 | 176 | 108 | 6 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.52e-06 | 176 | 108 | 6 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.52e-06 | 176 | 108 | 6 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-06 | 179 | 108 | 6 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-06 | 179 | 108 | 6 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | C_00|World / shred on cell type and cluster | 4.99e-06 | 179 | 108 | 6 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.99e-06 | 179 | 108 | 6 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.99e-06 | 179 | 108 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.99e-06 | 179 | 108 | 6 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.48e-06 | 182 | 108 | 6 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.48e-06 | 182 | 108 | 6 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.48e-06 | 182 | 108 | 6 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.48e-06 | 182 | 108 | 6 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-06 | 183 | 108 | 6 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-06 | 183 | 108 | 6 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-06 | 185 | 108 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.02e-06 | 185 | 108 | 6 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.21e-06 | 186 | 108 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.21e-06 | 186 | 108 | 6 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-06 | 188 | 108 | 6 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-06 | 188 | 108 | 6 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.81e-06 | 189 | 108 | 6 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.01e-06 | 190 | 108 | 6 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.01e-06 | 190 | 108 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.23e-06 | 191 | 108 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.23e-06 | 191 | 108 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 7.23e-06 | 191 | 108 | 6 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.90e-06 | 194 | 108 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 8.87e-06 | 198 | 108 | 6 | 86a4c8e859ce11a95875f8844963baeb1ba898ec | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 8.87e-06 | 198 | 108 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 8.87e-06 | 198 | 108 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.13e-06 | 199 | 108 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Transverse-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 9.13e-06 | 199 | 108 | 6 | 7cfe9b2538ea008d67343f3e8bfec3bf81200de6 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 9.13e-06 | 199 | 108 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.13e-06 | 199 | 108 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.70e-05 | 162 | 108 | 5 | 9f568836199a05f696294caac1ea3fa413984423 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-05 | 162 | 108 | 5 | bfaeff19bb56598fdc8c82be71d51787cf13928f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 163 | 108 | 5 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.13e-05 | 165 | 108 | 5 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 5.43e-05 | 167 | 108 | 5 | 82739226347d74897be000f429b73543a031af96 | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue | 5.43e-05 | 167 | 108 | 5 | dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-05 | 168 | 108 | 5 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 5.59e-05 | 168 | 108 | 5 | 494d5a11154ff22fedb25f4036d730cef376da60 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-05 | 169 | 108 | 5 | 301b96f376eff5491e5cf155fa14b306979afd27 | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.08e-05 | 171 | 108 | 5 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-05 | 172 | 108 | 5 | ddecdb1a0791296929790f78b49008f51a130f8b | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-05 | 172 | 108 | 5 | 62ed3b70fa1f6c84ea80ff00f60d2562be292e9d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 6.42e-05 | 173 | 108 | 5 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.42e-05 | 173 | 108 | 5 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 174 | 108 | 5 | 43c0e758fa8683708475aec846929ac70d41d7f5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.78e-05 | 175 | 108 | 5 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-05 | 175 | 108 | 5 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.15e-05 | 177 | 108 | 5 | c20df760b25caa772278397b02fc36521927cbfc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.15e-05 | 177 | 108 | 5 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.15e-05 | 177 | 108 | 5 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.15e-05 | 177 | 108 | 5 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-05 | 178 | 108 | 5 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-05 | 178 | 108 | 5 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.35e-05 | 178 | 108 | 5 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-05 | 178 | 108 | 5 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.54e-05 | 179 | 108 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-05 | 179 | 108 | 5 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.54e-05 | 179 | 108 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 7.74e-05 | 180 | 108 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.74e-05 | 180 | 108 | 5 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-05 | 180 | 108 | 5 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| Computational | Genes in the cancer module 451. | 7.67e-05 | 33 | 75 | 4 | MODULE_451 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.26e-07 | 191 | 108 | 9 | 4168_DN | |
| Drug | Reserpine | 1.61e-06 | 119 | 108 | 7 | ctd:D012110 | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 2124_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A | 4.93e-06 | 199 | 108 | 8 | 122_DN | |
| Drug | Guanabenz | 1.22e-05 | 10 | 108 | 3 | ctd:D006143 | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 3.70e-05 | 192 | 108 | 7 | 2865_DN | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 4.08e-05 | 195 | 108 | 7 | 5008_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 4.08e-05 | 195 | 108 | 7 | 6648_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 5340_DN | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 6792_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 5453_DN | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 7416_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; HL60; HG-U133A | 4.49e-05 | 198 | 108 | 7 | 1437_UP | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 4.64e-05 | 199 | 108 | 7 | 4633_DN | |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.64e-05 | 199 | 108 | 7 | 5466_DN | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.64e-05 | 199 | 108 | 7 | 6675_DN | |
| Drug | methenamine silver | 4.94e-05 | 201 | 108 | 7 | CID000004101 | |
| Drug | tyrphostin AG1296 | 5.62e-05 | 44 | 108 | 4 | CID000002049 | |
| Drug | 4-methylpyrimidine | 6.67e-05 | 3 | 108 | 2 | CID000018922 | |
| Drug | 2-(hydroxymethyl)-1,4-benzodioxan | 6.67e-05 | 3 | 108 | 2 | CID000019314 | |
| Drug | sialylphospholipid | 6.67e-05 | 3 | 108 | 2 | CID000515706 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 1.13e-08 | 8 | 107 | 4 | DOID:1858 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ABCA3 ATP7B KBTBD8 LRRC37A2 CLIP1 EMSY NCOR1 NAA25 FCRL3 LRRC37A MKI67 TENM1 GNAI2 PLD2 GOLGB1 | 7.80e-06 | 1074 | 107 | 15 | C0006142 |
| Disease | non-functioning pancreatic endocrine tumor (is_marker_for) | 1.30e-05 | 2 | 107 | 2 | DOID:7698 (is_marker_for) | |
| Disease | developmental cardiac valvular defect (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0080633 (implicated_via_orthology) | |
| Disease | four-jointed box protein 1 measurement | 3.90e-05 | 3 | 107 | 2 | EFO_0801605 | |
| Disease | Medullary Neoplasms | 7.78e-05 | 4 | 107 | 2 | C0751887 | |
| Disease | Brain Stem Neoplasms, Primary | 7.78e-05 | 4 | 107 | 2 | C0751886 | |
| Disease | Pontine Tumors | 7.78e-05 | 4 | 107 | 2 | C0751889 | |
| Disease | Mesencephalic Neoplasms | 7.78e-05 | 4 | 107 | 2 | C0751888 | |
| Disease | Brain Stem Neoplasms | 7.78e-05 | 4 | 107 | 2 | C0677866 | |
| Disease | sortilin measurement | 7.78e-05 | 4 | 107 | 2 | EFO_0600000 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 8.26e-05 | 63 | 107 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | migraine disorder, diastolic blood pressure | 1.01e-04 | 25 | 107 | 3 | EFO_0006336, MONDO_0005277 | |
| Disease | polyunsaturated fatty acid measurement | 1.18e-04 | 131 | 107 | 5 | EFO_0010733 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 1.29e-04 | 5 | 107 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.32e-04 | 71 | 107 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | liposarcoma | 1.94e-04 | 6 | 107 | 2 | C0023827 | |
| Disease | Atrial fibrillation | 1.94e-04 | 6 | 107 | 2 | cv:C0004238 | |
| Disease | emphysema imaging measurement | 1.96e-04 | 146 | 107 | 5 | EFO_0007626 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.56e-04 | 34 | 107 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | LDL cholesterol change measurement | 2.70e-04 | 7 | 107 | 2 | EFO_0007804 | |
| Disease | myocardial infarction | 2.94e-04 | 350 | 107 | 7 | EFO_0000612 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.60e-04 | 8 | 107 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | cathepsin Z measurement | 3.60e-04 | 8 | 107 | 2 | EFO_0008074 | |
| Disease | acid sphingomyelinase-like phosphodiesterase 3a measurement | 3.60e-04 | 8 | 107 | 2 | EFO_0008013 | |
| Disease | N-acylethanolamine-hydrolyzing acid amidase measurement | 4.61e-04 | 9 | 107 | 2 | EFO_0008240 | |
| Disease | glucose measurement | 4.81e-04 | 380 | 107 | 7 | EFO_0004468 | |
| Disease | serum gamma-glutamyl transferase measurement | RNF135 BACH1 MCC CDC42BPB EMSY CELSR2 NBEAL2 ABCB11 GNAI2 PLCE1 CDK6 | 4.92e-04 | 914 | 107 | 11 | EFO_0004532 |
| Disease | linoleic acid measurement | 5.96e-04 | 186 | 107 | 5 | EFO_0006807 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 6.28e-04 | 46 | 107 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 6.69e-04 | 47 | 107 | 3 | DOID:9074 (is_marker_for) | |
| Disease | metabolic syndrome | 8.27e-04 | 200 | 107 | 5 | EFO_0000195 | |
| Disease | factor XI measurement, coronary artery disease | 8.30e-04 | 115 | 107 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 8.51e-04 | 51 | 107 | 3 | EFO_0022242 | |
| Disease | Squamous cell carcinoma of the head and neck | 9.00e-04 | 52 | 107 | 3 | C1168401 | |
| Disease | chronic obstructive pulmonary disease | 9.11e-04 | 688 | 107 | 9 | EFO_0000341 | |
| Disease | phospholipids in large LDL measurement | 9.52e-04 | 53 | 107 | 3 | EFO_0022174 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 9.52e-04 | 53 | 107 | 3 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 9.52e-04 | 53 | 107 | 3 | EFO_0022258 | |
| Disease | atherosclerosis | 9.90e-04 | 13 | 107 | 2 | EFO_0003914 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.01e-03 | 54 | 107 | 3 | EFO_0022244 | |
| Disease | angina pectoris | 1.13e-03 | 125 | 107 | 4 | EFO_0003913 | |
| Disease | Hamman-Rich syndrome | 1.15e-03 | 14 | 107 | 2 | C0085786 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 1.15e-03 | 14 | 107 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | familial atrial fibrillation (is_implicated_in) | 1.15e-03 | 14 | 107 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.15e-03 | 14 | 107 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.17e-03 | 713 | 107 | 9 | EFO_0005689 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.18e-03 | 57 | 107 | 3 | EFO_0022284 | |
| Disease | low density lipoprotein particle size measurement | 1.24e-03 | 58 | 107 | 3 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.24e-03 | 58 | 107 | 3 | EFO_0022338 | |
| Disease | phospholipids in LDL measurement | 1.24e-03 | 58 | 107 | 3 | EFO_0022294 | |
| Disease | triglycerides to total lipids in small LDL percentage | 1.30e-03 | 59 | 107 | 3 | EFO_0022337 | |
| Disease | phospholipids in small LDL measurement | 1.30e-03 | 59 | 107 | 3 | EFO_0022297 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 1.33e-03 | 15 | 107 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | response to statin, LDL cholesterol change measurement | 1.33e-03 | 15 | 107 | 2 | EFO_0007804, GO_0036273 | |
| Disease | cardiovascular disease | 1.41e-03 | 457 | 107 | 7 | EFO_0000319 | |
| Disease | triglycerides to total lipids in IDL percentage | 1.57e-03 | 63 | 107 | 3 | EFO_0022329 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.57e-03 | 63 | 107 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.57e-03 | 63 | 107 | 3 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.64e-03 | 64 | 107 | 3 | EFO_0022253 | |
| Disease | Tactile Amnesia | 1.71e-03 | 17 | 107 | 2 | C0750906 | |
| Disease | Amnestic State | 1.71e-03 | 17 | 107 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 1.71e-03 | 17 | 107 | 2 | C0236795 | |
| Disease | Antihistamine use measurement | 1.71e-03 | 17 | 107 | 2 | EFO_0009943 | |
| Disease | Hysterical amnesia | 1.71e-03 | 17 | 107 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 1.71e-03 | 17 | 107 | 2 | C0233796 | |
| Disease | Amnesia | 1.71e-03 | 17 | 107 | 2 | C0002622 | |
| Disease | Global Amnesia | 1.71e-03 | 17 | 107 | 2 | C0262497 | |
| Disease | ascending aortic diameter | 1.72e-03 | 140 | 107 | 4 | EFO_0021787 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.80e-03 | 66 | 107 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 1.88e-03 | 67 | 107 | 3 | EFO_0022245 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.90e-03 | 144 | 107 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | migraine disorder, systolic blood pressure | 1.92e-03 | 18 | 107 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | type 1 diabetes mellitus | 1.92e-03 | 242 | 107 | 5 | MONDO_0005147 | |
| Disease | free cholesterol in large VLDL measurement | 1.96e-03 | 68 | 107 | 3 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.04e-03 | 69 | 107 | 3 | EFO_0022341 | |
| Disease | calcium measurement | 2.07e-03 | 628 | 107 | 8 | EFO_0004838 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 2.14e-03 | 19 | 107 | 2 | EFO_0802076 | |
| Disease | parental longevity | 2.19e-03 | 494 | 107 | 7 | EFO_0007796 | |
| Disease | metabolite measurement, diet measurement | 2.22e-03 | 71 | 107 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | aortic measurement | 2.25e-03 | 251 | 107 | 5 | EFO_0020865 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.32e-03 | 152 | 107 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in large LDL percentage | 2.49e-03 | 74 | 107 | 3 | EFO_0022280 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 2.59e-03 | 75 | 107 | 3 | EFO_0022287 | |
| Disease | Infiltrating duct carcinoma of female breast | 2.62e-03 | 21 | 107 | 2 | C3165106 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.62e-03 | 21 | 107 | 2 | EFO_0022246 | |
| Disease | Idiopathic Pulmonary Fibrosis | 2.62e-03 | 21 | 107 | 2 | C1800706 | |
| Disease | eosinophil count | CCDC170 CACHD1 IL1RL2 GTF3C4 EMSY ACTR1B MELTF NAA25 CMIP GNAI2 GNAO1 PLD1 CDK6 | 2.85e-03 | 1488 | 107 | 13 | EFO_0004842 |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 2.87e-03 | 22 | 107 | 2 | C1843687 | |
| Disease | asthma, allergic disease | 3.00e-03 | 79 | 107 | 3 | MONDO_0004979, MONDO_0005271 | |
| Disease | Mammary Carcinoma, Human | 3.06e-03 | 525 | 107 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.06e-03 | 525 | 107 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 3.13e-03 | 527 | 107 | 7 | C1458155 | |
| Disease | clinical and behavioural ideal cardiovascular health | 3.14e-03 | 23 | 107 | 2 | EFO_0007654 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.18e-03 | 166 | 107 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | aspartate measurement | 3.41e-03 | 24 | 107 | 2 | EFO_0010462 | |
| Disease | Dyslipidemias | 3.41e-03 | 24 | 107 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 3.41e-03 | 24 | 107 | 2 | C0598784 | |
| Disease | Breast Carcinoma | 3.50e-03 | 538 | 107 | 7 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VARTSLRTKVHAELA | 151 | P40227 | |
| DRKTEVDTSHRLSIF | 606 | Q7Z4L5 | |
| TDRVRTGESSVKDIH | 236 | O14867 | |
| SLVSSLHRDVTLTRE | 1026 | Q9BZ76 | |
| DVVASIHLSKRTVRR | 1306 | P35670 | |
| DTRSVHETRFEAAVK | 36 | Q5T8D3 | |
| HSRTTVKTITVSAEL | 486 | P06731 | |
| HTSAEFEVVRTIKER | 206 | P42025 | |
| REVALHERSSSVSTI | 3771 | Q8TCU4 | |
| RLKSVVVASSEIHVE | 391 | Q8IY22 | |
| HDKISVLTVADTVRT | 261 | Q5VU97 | |
| KISTQRHEVIRTTAS | 156 | Q71F23 | |
| RHEVIRTTASSELSE | 161 | Q71F23 | |
| HSDAAKTVTETVRRA | 86 | Q99758 | |
| ISVAHRLSTVRAADT | 611 | O95342 | |
| ADRTVVTIAHRVSSI | 1496 | O60706 | |
| SRTDRETKLTLVFEH | 86 | Q00534 | |
| ELDRETKSTHVFRVT | 246 | Q9HCU4 | |
| LRHRETIKSVASDET | 896 | Q6DHV5 | |
| TVFHIRIAEAKLTSV | 221 | Q9BXN1 | |
| RSHRIKTVVDLVSAD | 21 | O75771 | |
| RKTRHAELTVSLRVS | 86 | Q6ZSC3 | |
| RTRVKTTGIVETHFT | 176 | P63096 | |
| SSVRSTETHVERVLS | 1321 | Q9H3S7 | |
| RRLESIATTLVSHKA | 266 | Q9P2R3 | |
| EARRKAASTCTTHII | 231 | P58180 | |
| THAISILESAKARVT | 1276 | O60309 | |
| RESSRSHAVFTITIE | 231 | Q9NS87 | |
| THAISILESAKARVT | 1276 | A6NM11 | |
| THAISILESAKARVT | 1276 | A6NMS7 | |
| ETTARFRVETHTQKT | 811 | Q3T906 | |
| RTRVKTTGIVETHFT | 176 | P08754 | |
| ETALHLAVRSVDRTS | 586 | O43150 | |
| SVSSRIHEAVKAIVL | 536 | O43861 | |
| LSRHLREKTTIAVTS | 196 | Q5HYC2 | |
| VRAKASSVSLHAERT | 21 | Q8NHP7 | |
| HLVRTSRDSSTEKLL | 1426 | Q5VYK3 | |
| KRQEIRHGDSISITT | 386 | O95544 | |
| EVVDLSTTKSHRTVV | 2896 | Q9Y6V0 | |
| EEVSQTLRSKGHVSR | 356 | O95279 | |
| EARIVRVTHVSGKTL | 776 | Q9Y468 | |
| RSLDREETAIHKVTV | 316 | Q9HC56 | |
| TVTTVRKSSAVLEIH | 336 | Q6U736 | |
| HESRTNSDIVETLRK | 76 | Q06413 | |
| LAEAITLVESTHSRK | 101 | Q8IVH4 | |
| RVSAVEEVRSHVKVL | 231 | Q9UJY4 | |
| AILVSTVKSKRREHS | 66 | Q9Y6J6 | |
| AKTQEHTRTERSVLE | 76 | O75676 | |
| LEVVDTTASTKRHLR | 2711 | P46013 | |
| VSSVLASDVIHATRR | 1156 | Q9Y5S2 | |
| TQVTVEEHVFRTSRK | 541 | Q8NFY9 | |
| ESKRIREGVETHVSF | 276 | Q9HB29 | |
| EHTAVEKISSLVRRA | 186 | P52757 | |
| VSALERLTKSSEIRH | 741 | P23508 | |
| STKTERRSEIVMEHS | 1401 | Q9ULT8 | |
| DRTAIRSDTTHLVTL | 331 | Q9P2N7 | |
| SRTDREIKVTLVFEH | 81 | P11802 | |
| RHESVSKISTISSVR | 2586 | P15924 | |
| EVETVTHSIKKRSLR | 261 | Q96P31 | |
| RELKGHVISESRSID | 406 | Q9UH90 | |
| STSKIRTEITAHAAI | 116 | Q8IYT3 | |
| ELSKVLSISTERHRA | 51 | Q7Z589 | |
| HTVVLRVTATDRDKD | 561 | Q9NYQ7 | |
| VTRTDHQREITSLKE | 561 | P30622 | |
| DTLVTTKTRALTVAH | 356 | Q03701 | |
| SLVSSLHRDVTLTRE | 1026 | Q96NU0 | |
| VSAKRAVERHESLTS | 126 | Q5T6X4 | |
| TSIASLRRKALEHTV | 306 | Q5XKR4 | |
| MKTDVTRLTHSRDTE | 331 | Q9UNW8 | |
| GSKTRVTSHDREVDI | 546 | Q8TC56 | |
| SLEVSKDSRTVTVSH | 271 | Q8IUD6 | |
| SVMADKDTTRRIHVS | 316 | Q99523 | |
| AAAETETRTHTLTRV | 181 | O15240 | |
| AVVRRSSHVTIDTLK | 111 | P08582 | |
| ARRISVTSKVQADIH | 641 | Q8N5C8 | |
| ASRTTEDLFTVIHRS | 1106 | Q5HYW2 | |
| EHRLTDVGSVKRVTS | 491 | Q13393 | |
| INISKAHTVRRSGET | 36 | Q9P212 | |
| LRTRVKTTGIVETHF | 176 | P04899 | |
| RSVAVTKERSHVLVG | 2691 | Q6ZNJ1 | |
| LRTRVKTTGIVETHF | 176 | P09471 | |
| EDVKAGETVRSRHTS | 1436 | O75376 | |
| HSVSTDISLLREVVK | 246 | Q96T21 | |
| VSKVAIHSTLESARA | 1416 | Q9UKZ4 | |
| SVVSTVVRASKDLLH | 1911 | O75592 | |
| TRETARSTHVVLEKA | 281 | E7EW31 | |
| VVRSKAVSHRTISED | 501 | Q8TEV9 | |
| RAEVAVSVHLSTLSR | 331 | Q8IV77 | |
| KSSTEAVFHTVVLER | 106 | Q9HCG1 | |
| RDHSLASTSTKVRVV | 121 | Q9NZQ8 | |
| DIHSSVSRVGKAIDR | 81 | Q96G75 | |
| RTKEIELSRDSHVST | 11 | Q8N4C7 | |
| TVLSVGRFRVTKVEH | 221 | Q8IUW5 | |
| KERTATGLTHIIETR | 671 | Q709C8 | |
| HITAVLTKIIERDTS | 101 | Q9BWH6 | |
| HRVSVSTARSIAVLE | 76 | Q9UKN8 | |
| VTKSLHSIIRHREST | 431 | Q14166 | |
| RRFEDVSSEVSTLHK | 826 | Q9NRE2 | |
| TESDTAVRLRKSHTE | 556 | Q13464 | |
| SRVVHFAVLKAETVT | 246 | Q96MP5 | |
| SISVKIIRHDSRQDS | 726 | Q8TF01 | |
| VRRLFHKDLTSLETT | 151 | Q5VYS8 | |
| SVSADELVTRIHKVR | 96 | Q92575 | |
| KRSTEARHGVRIDTS | 271 | O14939 | |
| SAVSTVTKTERLVHS | 661 | P53814 | |
| VTKTERLVHSNDGTR | 666 | P53814 | |
| STDLAVRIQTHRSEK | 196 | Q14584 | |
| AERVRHISSKVEELS | 851 | Q14789 | |
| TVRLKVSSTAVRTQH | 726 | P01130 | |
| IEDRITEESKSSRHL | 306 | Q14CX7 | |
| ETDTIIFIRKAERSH | 891 | Q00872 |